Senolytics to remove senescent cells will deliver the first “repair” based approach to treat the aging process. This is the arrival of true rejuvenation biotechnology in the SENS model of damage repair.
Senescent cell removal with companies such as Unity, entering human clinical trials in the next 18 months will deliver the first true damage repair rejuevenation biotechnology. This will be the first “repair” approach to the aging process and one the SENS Research Foundation has been advocating for over a decade.
#aging #crowdfundthecure
Read more